title: Late anastomotic dehiscence during bevacizumab therapy for patients with colorectal cancer.
authors.forename: A
authors.initials: A
authors.lastname: Garant
authors.forename: S
authors.initials: S
authors.lastname: Des Groseilliers
authors.forename: L
authors.initials: L
authors.lastname: Martin
authors.forename: É
authors.initials: É
authors.lastname: Ferland
authors.forename: T
authors.initials: T
authors.lastname: Vuong
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy* / Q000601:surgery*; D057868:Anastomotic Leak / Q000139:chemically induced; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage / Q000009:adverse effects*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D000068258:Bevacizumab; D002166:Camptothecin / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000601:surgery*; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D002955:Leucovorin / Q000008:administration & dosage / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D060787:Neoplasm Grading; D009944:Organoplatinum Compounds / Q000008:administration & dosage / Q000009:adverse effects; D013529:Surgical Wound Dehiscence / Q000139:chemically induced*
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D009944:Organoplatinum Compounds; D000068258:Bevacizumab; D002955:Leucovorin; D005472:Fluorouracil; D002166:Camptothecin